lysuride

(redirected from Lisuride)
Also found in: Wikipedia.

lysuride

Lisuride, a DOPAMINE agonist drug used to treat Parkinson's disease. A brand name is Revanil.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
While 9 (9.2%) patients with Prolactinoma were given Cabergoline and 1 (1.0%) received Lisuride Maleate.
Indeed, compared to the baseline, [sup.11]C-raclopride binding was significantly decreased in the putamen and caudate nucleus in PD patients treated for 3-5 years with L-DOPA or lisuride, whereas no change was observed in D2 density 3-4 months posttreatment [64, 65].
66, psychoeducation PEG; 32, no psychoeducation Citation details Intervention; assessments Studies on supplements for mastalgia 1 Goyal [27] Evening primrose oil; low-fat, high-carbohydrate diet, lisuride, or vitamin E 2 Carmichael [52] Vitexagnus castus; Questionnaire: VAS, HAM-D, DSR CGI-SI, and DMS III-R 3 Romualdo et al [71] 900-mg borage oil capsules; assessed by VAS 4 Saeed et al.
It has been reported that treatment of prolactinoma with dopamine 2 receptor agonists such as bromocriptine, lisuride, cabergoline, and quinagolide may provoke the disease [9].
Exposicion a Cannabis, cocaina, extasis, anfetaminas, LSD, sustancias inhibidores de la recaptacion de serotonina, vasoactivas descongestionantes nasales, ergotamina, metergina, bromocriptina, lisuride, triptanes, isometeptina, parches de nicotina, ginseng.
(71), (72) Hormonal influences like prolactin and insulin can benefit from using prolactin-suppressing drugs like cabergoline (Dostinex[R]) (73) or Lisuride (74) and the insulin-suppressing drug metformin.
1990 Repeated administration of lisuride down-regulates dopamine D2 receptor function in mesostriatal and in mesolimbocortical rat brain regions.
[[.sup.11]C]-raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: influence of L-dopa and lisuride therapy on striatal dopamine D2 receptors.
Dentro del tratamiento farmacologico se han utilizado los agonistas dopaminergicos como bromocriptina, amantadina, apomorfina, lisuride y levodopa-carbidopa y relajantes musculares como el dantrolene.
Other drugs used for treatment of prolactinomas that have not been approved by the FDA include mesylate, lisuride and quinagolide (Shimon & Melmed, 1998).
Lisuride (not available in the US) with rescue levodopa vs levodopa alone had fewer motor complications at 4 years but lower UPDRS and activities of daily living scores.